LOMBARD MED INC's ticker is EVAR and the CUSIP is G55598109. A total of 11 filers reported holding LOMBARD MED INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,824,000 | -18.7% | 6,317,851 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $3,475,000 | -29.5% | 6,317,851 | 0.0% | 0.00% | -50.0% |
| Q1 2017 | $4,928,000 | +30.0% | 6,317,851 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $3,790,000 | -36.1% | 6,317,851 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $5,927,000 | -13.9% | 6,317,851 | 0.0% | 0.00% | -33.3% |
| Q2 2016 | $6,886,000 | +3.8% | 6,317,851 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $6,633,000 | -22.2% | 6,317,851 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $8,529,000 | -62.2% | 6,317,851 | 0.0% | 0.00% | -70.0% |
| Q3 2015 | $22,555,000 | -18.9% | 6,317,851 | 0.0% | 0.01% | -9.1% |
| Q2 2015 | $27,799,000 | +9.2% | 6,317,851 | 0.0% | 0.01% | +10.0% |
| Q1 2015 | $25,461,000 | -38.0% | 6,317,851 | 0.0% | 0.01% | -37.5% |
| Q4 2014 | $41,066,000 | – | 6,317,851 | 0.0% | 0.02% | – |
| Q3 2014 | $0 | – | 6,317,851 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 3,473,452 | $3,786,000 | 3.96% |
| SV Health Investors, LLC | 1,077,499 | $1,174,000 | 1.18% |
| Aisling Capital LLC | 886,363 | $966,000 | 0.23% |
| Texas Yale Capital Corp. | 29,062 | $32,000 | 0.00% |
| Verition Fund Management LLC | 19,129 | $21,000 | 0.00% |
| Invesco Ltd. | 6,317,851 | $6,886,000 | 0.00% |
| Citadel Advisors | 32,359 | $35,000 | 0.00% |
| BlackRock Fund Advisors | 12,633 | $14,000 | 0.00% |
| ROYAL BANK OF CANADA | 135 | $0 | 0.00% |
| MORGAN STANLEY | 1,863 | $2,000 | 0.00% |